PDS Biotechnology Corp Files 8-K: Material Agreement

Ticker: PDSB · Form: 8-K · Filed: Feb 28, 2025 · CIK: 1472091

Pds Biotechnology Corp 8-K Filing Summary
FieldDetail
CompanyPds Biotechnology Corp (PDSB)
Form Type8-K
Filed DateFeb 28, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, corporate-filing

TL;DR

PDS Biotech signed a material definitive agreement on Feb 26, 2025. Details to follow.

AI Summary

On February 26, 2025, PDS Biotechnology Corporation entered into a Material Definitive Agreement. The filing also notes other events and the submission of financial statements and exhibits. The company is incorporated in Delaware and headquartered in Princeton, NJ.

Why It Matters

This filing indicates a significant new agreement for PDS Biotechnology, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the nature of which is not yet fully disclosed.

Key Numbers

  • 001-37568 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 26-4231384 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • PDS Biotechnology Corporation (company) — Registrant
  • February 26, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • Princeton, NJ (location) — Principal Executive Offices
  • Edge Therapeutics, Inc. (company) — Former Company Name

FAQ

What is the nature of the Material Definitive Agreement entered into by PDS Biotechnology Corporation?

The filing states that PDS Biotechnology Corporation entered into a Material Definitive Agreement on February 26, 2025, but the specific details of this agreement are not provided in this excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 26, 2025.

Where is PDS Biotechnology Corporation's principal executive office located?

PDS Biotechnology Corporation's principal executive offices are located at 303A College Road East, Princeton, NJ 08540.

What was PDS Biotechnology Corporation's former company name?

PDS Biotechnology Corporation was formerly known as Edge Therapeutics, Inc.

What is the SIC code for PDS Biotechnology Corporation?

The Standard Industrial Classification (SIC) code for PDS Biotechnology Corporation is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding PDS Biotechnology Corp (PDSB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.